Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. (KMTS) priced its initial public offering on Mar 6, 2025 at $17.00 per share, raising $202M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $842.1M. BofA Securities was lead-left underwriter, joined by Goldman Sachs, Piper Sandler and Wells Fargo and others. Walkers and Kirkland & Ellis advised the company and A&O Shearman advised the underwriters.

Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on cardiovascular disease. Its Cardiac Recovery System integrates monitoring, therapeutic treatment, digital health and patient support services into a single solution.

Status

IPO

Ticker

KMTS

Exchange

Nasdaq Global Select

Priced

Mar 6, 2025

IPO price

$17.00

Raised

$202M

Market cap at IPO price

$842.1M

First filed

Feb 10, 2025

Underwriters

BofA Securities, Goldman Sachs, Piper Sandler, Wells Fargo, Stifel, Wolfe Research and Nomura

Company counsel

Walkers and Kirkland & Ellis

Underwriters' counsel

A&O Shearman

Sector

Healthcare

Country / state

WA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.